Standout Papers

B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis 2008 2026 2014 2020 1.8k
  1. B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis (2008)
    Stephen L. Hauser, Emmanuelle Waubant et al. New England Journal of Medicine
  2. Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis (2012)
    Ralf Gold, Ludwig Kappos et al. New England Journal of Medicine
  3. Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial (2012)
    Jeffrey Cohen, Alasdair Coles et al. The Lancet
  4. Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial (2012)
    Alasdair Coles, Cary Twyman et al. The Lancet
  5. Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials (2020)
    Ludwig Kappos, Jerry S. Wolinsky et al. JAMA Neurology
  6. How patients with multiple sclerosis acquire disability (2022)
    Fred Lublin, Dieter A. Häring et al. Brain
  7. Identifying multiple sclerosis subtypes using unsupervised machine learning and MRI data (2021)
    Arman Eshaghi, Alexandra L. Young et al. Nature Communications

Immediate Impact

2 by Nobel laureates 5 from Science/Nature 118 standout
Sub-graph 1 of 15

Citing Papers

Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis
2025 Standout
Neutrophil Membrane‐Camouflaged Polyprodrug Nanomedicine for Inflammation Suppression in Ischemic Stroke Therapy
2024 Standout
31 intermediate papers

Works of Douglas L. Arnold being referenced

Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
2012 Standout
B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
2008 Standout
and 30 more

Author Peers

Author Last Decade Papers Cites
Douglas L. Arnold 15391 6352 6243 6955 687 31.4k
Gıancarlo Comı 17201 4923 6205 10041 752 35.3k
Peter A. Calabresi 15786 5781 7324 5648 541 34.2k
W. I. McDonald 21988 4226 4293 9862 248 31.3k
David H. Miller 28020 9455 5630 10951 386 39.2k
Hans‐Peter Hartung 20245 3627 7771 14180 728 42.0k
Jeffrey A. Cohen 12816 2387 3989 5496 305 22.0k
Xavier Montalbán 28429 2499 6944 11557 748 38.0k
Jerry S. Wolinsky 22921 3146 3211 8479 241 27.9k
Fred Lublin 29631 3029 4718 10313 239 36.3k
Tomas Olsson 14064 1708 5685 5458 673 30.4k

All Works

Loading papers...

Rankless by CCL
2026